Related Experiment Video
Updated: Jun 5, 2025

10:26
Author Spotlight: A 3D Digital Model for the Diagnosis and Treatment of Pulmonary Nodules
Published on: May 19, 2023
1.8K
Ultra-low-dose chest computed tomography with model-based iterative reconstruction in the analysis of solid pulmonary
Patrick W O'Regan1, Antonia Harold-Barry2, Alexander T O'Mahony2
1Department of Radiology, School of Medicine, University College Cork, Cork T12 AK54, Ireland. patrickoregan@ucc.ie.
World Journal of Radiology
|December 5, 2024
Summary
Ultra-low-dose CT (ULDCT) with model-based iterative reconstruction (MBIR) effectively analyzes pulmonary nodules, matching standard-dose CT (SDCT) performance while significantly reducing radiation exposure for patients.
Area of Science:
- Radiology
- Medical Imaging
- Pulmonology
Background:
- Incidental pulmonary nodules are common on CT scans.
- Distinguishing benign from malignant nodules is challenging.
- Ultra-low-dose CT (ULDCT) shows promise for respiratory pathology diagnosis.
Purpose of the Study:
- To compare ULDCT with model-based iterative reconstruction (MBIR) against standard-dose CT (SDCT) for analyzing solid pulmonary nodules.
- To evaluate diagnostic accuracy, image quality, and radiation dose.
Main Methods:
- Prospective cohort study of 30 adult patients with indeterminate pulmonary nodules.
- Acquisition of both reference SDCT and immediate ULDCT chest scans.
- Comparison of nodule identification, characterization, measurement, image quality, and radiation dose.
Main Results:
- ULDCT detected 100 nodules, SDCT detected 98; no significant difference in characteristics of correctly identified nodules.
- Signal-to-noise ratio increased in ULDCT (except paraspinal muscle).
- Mean subjective image quality score was 8.9/10.
- ULDCT protocol resulted in a 97.6% radiation dose reduction compared to SDCT.
Conclusions:
- ULDCT with MBIR is non-inferior to SDCT for analyzing previously identified solid pulmonary nodules.
- This technique significantly reduces radiation dose.
- ULDCT offers a safe and effective alternative for pulmonary nodule surveillance.

